Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial
Highlights • Women have a higher risk for anthrax vaccine adsorbed (AVA)-associated injection site AEs. • We analyzed data from the CDC AVA human clinical trial for 8 injection site AEs. • Female and non-black participants had a higher proportion of AVA-associated AEs. • Female and non-black partici...
Saved in:
Published in | Vaccine Vol. 32; no. 28; pp. 3548 - 3554 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier
12.06.2014
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Highlights • Women have a higher risk for anthrax vaccine adsorbed (AVA)-associated injection site AEs. • We analyzed data from the CDC AVA human clinical trial for 8 injection site AEs. • Female and non-black participants had a higher proportion of AVA-associated AEs. • Female and non-black participants also had higher anti-PA IgG concentrations. • Antibody responses to other vaccines may also vary by gender and race. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2014.04.025 |